References
- SuSEpidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in ChinaTrends Microbiol.201725 713 72810.1016/j.tim.2017.06.008
- WuYWuYTefsenBShiYGaoGFBat-derived influenza-like viruses H17N10 and H18N11Trends Microbiol.20142218319110.1016/j.tim.2014.01.010
- SunXBat-derived influenza hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a unique entry mechanismCell Rep.2013376977810.1016/j.celrep.2013.01.025
- SuzukiYSialic acid species as a determinant of the host range of influenza A virusesJ. Virol.200074118251183110.1128/JVI.74.24.11825-11831.2000
- GambaryanAS6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultryVirol. J.200858510.1186/1743-422X-5-85
- HionoTA chicken influenza virus recognizes fucosylatedalpha2,3 sialoglycan receptors on the epithelial cells lining upper respiratory tracts of chickensVirology2014456-45713113810.1016/j.virol.2014.03.004
- ShiYStructures and receptor binding of hemagglutinins from human-infecting H7N9 influenza virusesScience201334224324710.1126/science.1242917
- TanMJiangXNorovirus and its histo-blood group antigen receptors: an answer to a historical puzzleTrends Microbiol.20051328529310.1016/j.tim.2005.04.004
- TanMJiangXNorovirus gastroenteritis, carbohydrate receptors, and animal modelsPLoS Pathog.20106e100098310.1371/journal.ppat.1000983
- TanMJiangXNorovirus-host interaction: multi-selections by human histo-blood group antigensTrends Microbiol.20111938238810.1016/j.tim.2011.05.007
- TanMJiangXHisto-blood group antigens: a common niche for norovirus and rotavirusExpert Rev. Mol. Med.201416e510.1017/erm.2014.2
- JiangXLiuYTanMHisto-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategyEmerg. Microbes Infect.20176e2210.1038/emi.2017.30
- DuBoisRMThe receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structureJ. Virol.20118586587210.1128/JVI.01412-10
- XuRPreferential recognition of avian-like receptors in human influenza A H7N9 virusesScience20133421230123510.1126/science.1243761
- TharakaramanKGlycan receptor binding of the influenza A virus H7N9 hemagglutininCell20131531486149310.1016/j.cell.2013.05.034
- TanMJiangXNorovirus-host interaction: implications for disease control and preventionExpert Rev. Mol. Med.2007912210.1017/S1462399407000348
- Everest-DassAVComparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicansGlycobiology2012221465147910.1093/glycob/cws112
- LimsuwatNSialic acid content in human saliva and anti-influenza activity against human and avian influenza virusesArch. Virol.201616164965610.1007/s00705-015-2700-z
- LiuYGlycan specificity of P[19] rotavirus and comparison with those of related P genotypesJ. Virol.2016909983999610.1128/JVI.01494-16
- LiuYStructural basis of glycan specificity of P[19] VP8*: implications for rotavirus zoonosis and evolutionPLoS Pathog.201713e100670710.1371/journal.ppat.1006707
- LiuBClusters of human infections with avian influenza A(H7N9) virus in China, March 2013 to June 2015J. Infect. Dis.2017216suppl_4S548S55410.1093/infdis/jix098
- TanMOutbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infectionJ. Med. Virol.2008801296130110.1002/jmv.21200
- WangLPolyvalent complexes for vaccine developmentBiomaterials2013344480449210.1016/j.biomaterials.2013.02.041
- XiaMA trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirusVaccine20163490591310.1016/j.vaccine.2015.12.068
- ZhangDTulane virus recognizes the A-type 3 and B histo-blood group antigensJ. Virol.2014891419142710.1128/JVI.02595-14
- HuangPNorovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patternsJ. Virol.2005796714672210.1128/JVI.79.11.6714-6722.2005
- WangLBranched-linear and agglomerate protein polymers as vaccine platformsBiomaterials2014358427843810.1016/j.biomaterials.2014.06.021